MENU
+Compare
ABBV
Stock ticker: NYSE
AS OF
Jun 25, 04:59 PM (EDT)
Price
$185.43
Change
-$0.12 (-0.06%)
Capitalization
322.43B

ABBV ABBVIE Forecast, Technical & Fundamental Analysis

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ABBV with price predictions
Jun 24, 2025

Momentum Indicator for ABBV turns negative, indicating new downward trend

ABBV saw its Momentum Indicator move below the 0 level on June 17, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned negative. In of the 79 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ABBV turned negative on June 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABBV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

ABBV moved above its 50-day moving average on June 24, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ABBV crossed bullishly above the 50-day moving average on June 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABBV advanced for three days, in of 360 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 350 cases where ABBV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ABBV's P/B Ratio (30.864) is very high in comparison to the industry average of (5.632). P/E Ratio (66.456) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.499) is also within normal values, averaging (3.004). Dividend Yield (0.033) settles around the average of (0.161) among similar stocks. P/S Ratio (5.900) is also within normal values, averaging (3.643).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ABBV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABBV is expected to report earnings to rise 30.89% to $3.22 per share on July 25

ABBVIE ABBV Stock Earnings Reports
Q2'25
Est.
$3.22
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.08
Q2'24
Missed
by $0.05
The last earnings report on April 25 showed earnings per share of $2.46, beating the estimate of $2.39. With 4.46M shares outstanding, the current market capitalization sits at 322.43B.
A.I.Advisor
published Dividends

ABBV paid dividends on May 15, 2025

ABBVIE ABBV Stock Dividends
А dividend of $1.64 per share was paid with a record date of May 15, 2025, and an ex-dividend date of April 15, 2025. Read more...
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHH31.431.32
+4.38%
Park Ha Biological Technology Co Ltd
TE1.370.05
+3.79%
T1 Energy Inc.
C81.141.78
+2.24%
Citigroup
IFRX0.800.01
+0.88%
InflaRx NV
AVDL9.600.06
+0.63%
Avadel Pharmaceuticals plc

ABBV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with PFE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
+0.97%
PFE - ABBV
54%
Loosely correlated
+1.17%
AMGN - ABBV
49%
Loosely correlated
+1.85%
NVS - ABBV
45%
Loosely correlated
+1.11%
JNJ - ABBV
44%
Loosely correlated
+0.57%
GILD - ABBV
41%
Loosely correlated
+0.95%
More